Warning letter
BC Group International, Inc. [ARCHIVED]: warning letter of Mar 23, 2011
FDA warning letter 159519 · Kansas City District Office
Key facts
| Reference number | 159519 |
|---|---|
| Company | BC Group International, Inc. [ARCHIVED] |
| Subject | CGMP/QSR/Manufacture/Packing/Storage/Installation/Adulterated |
| Issue date | Mar 23, 2011 |
| Posted date | Mar 23, 2011 |
| Issuing office | Kansas City District Office |
| Product type | Devices |
| CFR sections cited | 807.81(b), 820 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: